Saturday, July 11, 2026

pharma · Helicobacter Pylori · Type 2 Diabetes

Shandong Jinpharm Co.,Ltd

Shandong Jinpharm Co.,Ltd trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Linyi, CN HQ
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Linyi, CN
Employees
5
Programs
3
Drugs
5
Patents
0
Intelligence · Clinical Trials

Shandong Jinpharm Co.,Ltd clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Shandong Jinpharm Co.,Ltd programs — each row shows trial ID, program name, phase, status, and indication.

Shandong Jinpharm Co.,Ltd trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Shandong Jinpharm Co.,Ltd.

  1. bismuth-containing quadral therapy based on antibiotic susceptibility — Unknown

    Clinical update
  2. MSC — Phase 2

    Clinical update
  3. placebo — Approved

    Clinical update

Trial registry

3 studies